✦ LIBER ✦

PD23 Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer

✍ Scribed by Bauer, J.A.; Kumar, B.; Cordel, K.G.; Lee, J.S.; Prince, M.E.; Tran, H.H.; Wolf, G.T.; Urba, S.G.; Worden, F.P.; Chepeha, D.B.; Teknos, T.N.; Eisbruch, A.; Tsien, C.I.; Griffith, K.A.; Taylor, J.M.G.; D'Silva, N.J.; Wang, S.; Wang, S.J.; Wolter, K.G.; Henson, B.; Carey, T.E.; Bradford, C.R.

Book ID: 118655668
Publisher: Elsevier Science
Year: 2007
Weight: 59 KB
Volume: 2
Category: Article
ISSN: 1744-7895
DOI: 10.1016/s1744-7895(07)70174-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel targets in HPV-negative head and n

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

✍ Burtness, Barbara; Bauman, Julie E; Galloway, Thomas 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 964 KB

Overcoming resistance to EGFR inhibitor

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

✍ Guilherme Rabinowits; Robert I. Haddad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 177 KB

A pilot study of a randomized controlled

A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors

✍ Margaret L. McNeely; Matthew Parliament; Kerry S. Courneya; Hadi Seikaly; Naresh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## Background. Shoulder dysfunction remains a frequent complication after neck dissection procedures for head and neck cancer. ## Methods. We conducted a pilot study to evaluate the effects of progressive resistance exercise training (PRET) on shoulder dysfunction caused by spinal ac

207 POSTER Phase II study of gefitinib i

207 POSTER Phase II study of gefitinib in combination with cisplatin and concurrent radiotherapy in patients with stage III/IV squamous cell head and neck cancer and to analyse the effect of gefitinib on tumour gene expression

✍ E.H. Tan; C. Goh; A. Loy; S.S. Leong; W.T. Lim; C.K. Toh; T. Tan; J. Wee; K.W. F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

8517 Phase I results from an open-label,

8517 Phase I results from an open-label, randomized, controlled, phase I/II study (ADVANTAGE) to evaluate the combination of different cilengitide regimens with cisplatin, 5-FU, and cetuximab in patients with recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)

✍ Brümmendorf, T.; Guigay, J.; Mesía, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB